Axsome Therapeutics (AXSM) Return on Capital Employed (QoQ) (2016 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Axsome Therapeutics | 11.82 Bn | 11.51 Bn | 176.48 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -429.00 |
| Dec 31, 2025 | 5,940.00 |
| Sep 30, 2025 | 1,071.00 |
| Jun 30, 2025 | -311.00 |
| Mar 31, 2025 | 398.00 |
| Dec 31, 2024 | 160.00 |
| Sep 30, 2024 | -55.00 |
| Jun 30, 2024 | -1,561.00 |
| Mar 31, 2024 | -1,834.00 |
| Dec 31, 2023 | -1,152.00 |
| Sep 30, 2023 | 573.00 |
| Jun 30, 2023 | 1,187.00 |
| Mar 31, 2023 | 1,839.00 |
| Dec 31, 2022 | 111.00 |
| Sep 30, 2022 | 7,953.00 |
| Jun 30, 2022 | 5,645.00 |
| Mar 31, 2022 | -5,482.00 |
| Dec 31, 2021 | -4,371.00 |
| Sep 30, 2021 | -3,254.00 |
| Jun 30, 2021 | -2,032.00 |
| Mar 31, 2021 | -320.00 |
| Dec 31, 2020 | -368.00 |
| Sep 30, 2020 | 49.00 |
| Jun 30, 2020 | -585.00 |
| Mar 31, 2020 | 1,348.00 |
| Dec 31, 2019 | 4,502.00 |
| Sep 30, 2019 | -4,480.00 |
| Jun 30, 2019 | 1,596.00 |
| Mar 31, 2019 | 20,439.00 |
| Dec 31, 2018 | -7,049.00 |
| Sep 30, 2018 | -19,660.00 |
| Jun 30, 2018 | -7,098.00 |
| Mar 31, 2018 | -6,875.00 |
| Dec 31, 2017 | 2,062.00 |
| Sep 30, 2017 | 1,859.00 |
| Jun 30, 2017 | -162.00 |
| Mar 31, 2017 | -732.00 |
| Dec 31, 2016 | 1,861.00 |
| Sep 30, 2016 | 2,735.00 |
| Jun 30, 2016 | 1,730.00 |